{"DataElement":{"publicId":"2431605","version":"1","preferredName":"Prostate Additional Findings Findings NCI Concept Code","preferredDefinition":"Significant pathologic finding present in addition to the invasive prostate carcinoma.","longName":"2431396v1.0:2433709v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431396","version":"1","preferredName":"Prostate Gland Additional Finding Finding","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system.  It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra.  The prostate gland secretes a fluid which is part of the semen.:Added; extra.:The result of an examination or inquiry._Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.","longName":"2431296v1.0:2241301v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431296","version":"1","preferredName":"Prostate Gland Additional Finding","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system.  It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra.  The prostate gland secretes a fluid which is part of the semen.:Added; extra.:The result of an examination or inquiry.","longName":"C12410:C25406:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF4CC-435C-3C03-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241301","version":"1","preferredName":"Finding","preferredDefinition":"Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.","longName":"C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAB2D8EC-6E04-68CB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE0D0E-A12A-4539-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Permission to Release DEC granted by primary curator in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2433709","version":"1","preferredName":"Prostate Additional Findings Findings NCI Concept Code","preferredDefinition":"Additional prostate specific findings._A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"2433709v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None identified","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4E2-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"High-grade prostatic intraepithelial neoplasia (PIN)","valueDescription":"High Grade Prostatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"2581149","version":"1","preferredName":"High Grade Prostatic Intraepithelial Neoplasia","longName":"2581149","preferredDefinition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts. The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoloplasmic ratio. The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform. The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Prostatic Intraepithelial Neoplasia","conceptCode":"C5541","definition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts.  The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoplasmic ratio.  The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform.  The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4E4-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Atypical adenomatous hyperplasia","valueDescription":"Prostatic Atypical Adenomatous Hyperplasia","ValueMeaning":{"publicId":"2577202","version":"1","preferredName":"Prostatic Atypical Adenomatous Hyperplasia","longName":"2577202","preferredDefinition":"A prostatic hyperplasia characterized by the presence of crowded adenomatous epithelial nodules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostatic Atypical Adenomatous Hyperplasia","conceptCode":"C5595","definition":"A prostatic hyperplasia characterized by the presence of crowded adenomatous epithelial nodules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA9F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4E7-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Benign prostatic hyperplasia","valueDescription":"Benign Prostatic Hyperplasia","ValueMeaning":{"publicId":"2577137","version":"1","preferredName":"Benign Prostatic Hyperplasia","longName":"2577137","preferredDefinition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Prostatic Hyperplasia","conceptCode":"C2897","definition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4EA-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Inflammation","valueDescription":"Inflammation","ValueMeaning":{"publicId":"2581231","version":"1","preferredName":"Inflammation","longName":"2581231","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-17","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06BB6599-42B0-21F1-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-29","modifiedBy":"ONEDATA","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"Other (specify)","valueDescription":"Other Specify","ValueMeaning":{"publicId":"4188777","version":"1","preferredName":"Other Specify","longName":"4188777","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3CC9DDB-CE4D-9879-E040-BB89AD430A03","latestVersionIndicator":"Yes","beginDate":"2014-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D47107A-E24A-3F37-E053-F662850A0810","beginDate":"2019-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433292","version":"1","preferredName":"NCI Concept Code","preferredDefinition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"C43516","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI Concept Code","conceptCode":"C43516","definition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"062A6784-EC8C-6CFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-22","modifiedBy":"ONEDATA","dateModified":"2005-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06459C26-C343-6BA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812224","version":"1","longName":"edu.pitt.cabig.cae.domain.prostate","context":"NCIP"}]},{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812065","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.prostate","context":"NCIP"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000016","version":"1","longName":"Prostate","context":"OCG"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.prostate.ProstateAdditionalFindings.findings","type":"UML Qualified Attr","context":"NCIP"},{"name":"edu.upmc.opi.cabig.caties.cap.domain.prostate.ProstateAdditionalFindings.findings","type":"UML Qualified Attr","context":"NCIP"},{"name":"ProstateAdditionalFindings:findings","type":"UML Class:UML Attr","context":"NCIP"},{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Additional Pathologic Findings","type":"Preferred Question Text","description":"Additional Pathologic Findings","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE7B2D-C624-64BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-09","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}